LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

ORBIMED ADVISORS LLC's Holding History (CIK: 0001055951)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 3,103,623 Value ($000) $1,986 Avg Close — Range —
Q3 2024
Shares 6,086,001 Value ($000) $8,399 Avg Close — Range —
Q2 2024
Shares 6,405,098 Value ($000) $9,287 Avg Close — Range —
Q1 2024
Shares 199,500 Value ($000) $445 Avg Close — Range —